Mechanism Of Action
Mechanism of Action
Explore how drugs produce their pharmacological effects at the molecular, cellular, tissue, and systemic levels. Learn about drug targets, receptors, enzymes, ion channels, transporters, signaling pathways, and downstream biological responses.
What Is Mechanism of Action?
Mechanism of action (MOA) describes the specific biochemical interaction through which a drug produces its pharmacological effect. It explains what a drug interacts with, how that interaction changes cellular or physiological processes, and how those changes ultimately produce the therapeutic or adverse effects of the drug.
A drug’s mechanism may involve binding to a receptor, inhibiting or activating an enzyme, blocking an ion channel, modifying a transporter, altering gene expression, interacting with DNA, or changing a signaling pathway.
How Does a Drug Produce Its Effect?
Drug action can be understood as a sequence of events beginning with the drug reaching its biological target and ending with a measurable pharmacological response.
Major Drug Targets
Most drugs act by interacting with specific biological macromolecules. The major classes of pharmacological targets include:
Receptors
Proteins that detect endogenous signaling molecules and translate extracellular signals into cellular responses.
Enzymes
Catalytic proteins involved in biochemical reactions. Drugs may inhibit or activate enzymes to alter metabolic pathways.
Ion Channels
Membrane proteins that regulate ion movement across cell membranes. Channel blockers and modulators can alter cellular excitability.
Transporters
Proteins responsible for moving molecules across membranes. Drugs can inhibit or modify transporter activity.
Nucleic Acids
Some drugs interact with DNA or RNA to modify replication, transcription, translation, or gene expression.
Structural Proteins
Certain drugs interact with structural proteins and alter cellular architecture, division, or movement.
Drug–Receptor Mechanisms
Receptors are among the most important targets in pharmacology. Drugs can either mimic endogenous ligands or interfere with receptor signaling.
Agonists
An agonist binds to a receptor and produces receptor activation. Depending on the receptor and signaling system, activation can stimulate or inhibit a physiological process.
Antagonists
An antagonist binds to a receptor but does not produce the activating response. It prevents or reduces the action of an agonist or endogenous ligand.
Partial Agonists
A partial agonist activates a receptor but produces a lower maximal response than a full agonist, even when occupying a large proportion of available receptors.
Inverse Agonists
An inverse agonist preferentially reduces constitutive receptor activity when a receptor exhibits activity in the absence of an activating ligand.
Enzyme-Based Mechanisms
Many important medicines act by modifying enzyme activity. Enzyme inhibition may decrease the production of a biological mediator or increase the concentration of a substrate.
| Mechanism | Description | Example |
|---|---|---|
| Competitive inhibition | Drug competes with substrate for the enzyme’s active site. | Statins inhibit HMG-CoA reductase. |
| Irreversible inhibition | Drug produces long-lasting enzyme inhibition, often through covalent modification. | Aspirin irreversibly inhibits COX enzymes. |
| Allosteric modulation | Drug binds at a site different from the active site and modifies enzyme activity. | Various enzyme modulators. |
Ion Channel Mechanisms
Ion channels control the movement of ions such as sodium, potassium, calcium, and chloride across biological membranes. Drugs that modify these channels can significantly influence membrane potential and cellular excitability.
Local anesthetics such as lidocaine inhibit voltage-gated sodium channels, reducing sodium influx and preventing propagation of action potentials in neurons.
Drugs such as amlodipine reduce calcium entry through specific voltage-dependent calcium channels, contributing to vascular smooth muscle relaxation and reduced blood pressure.
Transporter-Based Mechanisms
Transport proteins regulate the movement of endogenous substances and drugs across cell membranes. Inhibition or modification of transporters can change neurotransmitter concentrations, renal drug handling, or intestinal absorption.
SSRIs inhibit the serotonin transporter, reducing serotonin reuptake into presynaptic neurons and increasing serotonergic signaling in relevant neural circuits.
Cellular Signaling Pathways
Drug–target interactions can trigger complex intracellular signaling cascades. These pathways may involve second messengers, protein kinases, transcription factors, ion concentrations, and changes in gene expression.
G-Protein-Coupled Receptors
GPCRs can activate intracellular pathways involving cyclic AMP, phospholipase C, intracellular calcium, and other signaling mediators.
Receptor Tyrosine Kinases
Activation of receptor tyrosine kinases can initiate phosphorylation cascades involving pathways such as PI3K/AKT and MAPK/ERK.
Intracellular Receptors
Some lipophilic drugs enter cells and interact with intracellular receptors. The resulting drug–receptor complex can regulate gene transcription and produce relatively prolonged biological effects.
Examples of Drug Mechanisms of Action
Metformin primarily reduces hepatic glucose production and improves insulin sensitivity. Its pharmacological effects involve complex cellular pathways including AMPK-associated signaling and mitochondrial metabolic effects.
Omeprazole is activated in the acidic environment of gastric parietal cell canaliculi and inhibits the gastric H⁺/K⁺-ATPase, thereby suppressing gastric acid secretion.
Atorvastatin inhibits HMG-CoA reductase, an important enzyme in hepatic cholesterol synthesis. Reduced hepatic cholesterol synthesis contributes to increased hepatic LDL receptor activity and enhanced removal of LDL particles from the circulation.
Losartan selectively blocks angiotensin II type 1 receptors, reducing angiotensin II-mediated vasoconstriction and aldosterone-related effects.
Salbutamol activates β₂-adrenergic receptors, increasing intracellular cyclic AMP in airway smooth muscle and promoting bronchodilation.
Mechanism of Action vs Pharmacodynamics
| Concept | Meaning |
|---|---|
| Mechanism of Action | Describes how a drug interacts with its molecular target to produce an effect. |
| Pharmacodynamics | Describes the relationship between drug concentration/exposure and the resulting biological effects. |
| Pharmacokinetics | Describes what the body does to the drug, including absorption, distribution, metabolism, and excretion. |
Why Mechanism of Action Is Important
- Helps explain how a medicine produces therapeutic effects.
- Provides a molecular basis for understanding drug activity.
- Helps predict potential adverse effects.
- Supports understanding of drug–drug interactions.
- Helps identify potential contraindications.
- Provides a foundation for drug discovery and development.
- Helps researchers understand resistance mechanisms.
- Supports rational selection of pharmacological therapies.
Frequently Asked Questions
What does MOA mean in pharmacology?
MOA means mechanism of action. It describes how a drug interacts with a biological target and produces its pharmacological effect.
What are the main drug targets?
Major drug targets include receptors, enzymes, ion channels, transporters, nucleic acids, and structural proteins.
Is mechanism of action the same as pharmacodynamics?
No. Mechanism of action describes the molecular process through which a drug produces an effect, whereas pharmacodynamics broadly describes the relationship between drug exposure and biological response.
Why is MOA important in drug monographs?
A mechanism-of-action section helps readers understand why a drug produces its therapeutic effects and how its molecular target relates to its clinical pharmacology.
Can one drug have more than one mechanism?
Yes. Some drugs interact with multiple molecular targets or produce secondary effects through downstream signaling pathways.
Explore PharmacologyInfo
Explore detailed drug monographs, drug classes, pharmacological targets, mechanisms of action, pharmacokinetics, pharmacodynamics, adverse effects, and clinical information.